Abstract: The present invention relates to a method of fabricating a programmable and/or reprogrammable magnetic soft device having a Young's modulus of less than 500 MPa in a part of the device. The invention further relates to an untethered programmable and/or reprogrammable, in particular 3D, magnetic soft device having a part with Young's modulus of less than 500 MP, to a method of encoding a programmable and/or reprogrammable magnetic soft device, and to a use of a programmable and/or reprogrammable magnetic soft device.

Abstract: The invention relates to a method of assembling mobile micro-machines comprising a main body and at least one actuating element, wherein the method comprises the steps of defining a 3D-shape of elements of the mobile micro-machines, the elements comprising components such as the main body and/or the at least one actuating element; fabricating said elements, said step of fabrication comprising at least the fabrication of the main body, the main body comprising one or more edges; and assembling said mobile micro-machines by applying an external electric field, wherein said external electric field forms electric field gradients at said one or more edges and wherein said gradients attract said actuating element so that the main body and the at least one actuating element self-assemble into a micro-machine at said one or more edges. The invention further relates to a mobile micro-machine.

Abstract: A microfluidic biochip device includes a housing including at least one microchannel defining at least one cell adhesion region. The at least one cell adhesion region is provided with at least one capturing agent that adheres a cell of interest to a surface of the at least one microchannel when a fluid sample containing cells is passed through the at least one microchannel. An imaging system measures the morphology and/or quantity of cells of interest adhered by the at least one capturing agent to the surface of the at least one microchannel when the fluid sample is passed therethrough.

Abstract: A biochip compatible with very small blood sample volumes is used for delecting for detecting hemoglobin disorders and monitoring disorders associated with aberrant blood cell deformability and adhesion, including disease severity, upcoming pain crisis, treatment response, and treatment effectiveness in a clinically meaningful way.